1st Quarter - Amendment

CEPHEID for CEPHEID

Firm
Client
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 20, 2009 $60,000 Replaced
1st Quarter - Report Jul 15, 2009 $60,000 Replaced
1st Quarter - Amendment Jul 15, 2009 $60,000 Replaced
1st Quarter - Amendment (this page) Jul 15, 2009 $60,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S 30 Physician Payments Sunshine Act of 2009, HR 1 American Recovery and Reinvestment Act of 2009 HR 805 Strengthening America's Public Health System Act, HR 1105 Omnibus Appropriations Act, 2009, HR 1452 Updating the Clinical Laboratory Fee Schedule HR 1691, Patient Access to Critical Lab Tests Act

LobbyistCovered position, as disclosed
HALLIE CHRISTINE LEWIS Manager, Government Relations
MICHELE M SCHOONMAKER Director, Government Affairs

Contacted: Natl Institutes of Health (NIH); Medicare Payment Advisory Commission (MedPAC); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1452 (111th), H.R. 805 (111th), H.R. 1691 (111th), H.R. 1105 (111th), H.R. 1 (111th)

Medical/Disease Research/Clinical Labs MED

S 30 Physician Payments Sunshine Act of 2009, HR 1 American Recovery and Reinvestment Act of 2009 HR 805 Strengthening America's Public Health System Act, HR 1105 Omnibus Appropriations Act, 2009, HR 1452 Updating the Clinical Laboratory Fee Schedule HR 1691, Patient Access to Critical Lab Tests Act

LobbyistCovered position, as disclosed
HALLIE CHRISTINE LEWIS Manager, Government Relations
MICHELE M SCHOONMAKER Director, Government Affairs

Contacted: Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); SENATE; Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1105 (111th), H.R. 1691 (111th), H.R. 805 (111th), H.R. 1 (111th), H.R. 1452 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.